WHICH DOCTORS ARE ALLOWED TO PRESCRIBE MEDICAL CANNABIS?
DOES THE STATUTORY HEALTH INSURANCE PAY FOR CANNABIS MEDICINES?
Patients with a serious illness are entitled to benefits if a generally recognized treatment that meets medical standards is not available or, in the individual case, cannot be used for the patient in the opinion of the doctor.
Furthermore, there must be a prospect of a noticeably positive effect on the course of the disease or on the alleviation of severe symptoms.
In the case of initial prescription, reimbursement must be approved by the health insurance fund before the start of cannabis therapy.
In the case of reimbursement by the statutory health insurance, patients are obliged to participate in an anonymized accompanying study.
CAN THE VERIFICATION BY THE HEALTH INSURANCE FUND AND THE MEDICAL SERVICE BE WAIVED?
The statutory health insurance funds conduct a verification for each application, usually with the involvement of the Medical Service.
If medical cannabis is obtained on a private prescription, the aforementioned examination by the health insurance fund or the Medical Service does not take place.
If a private health insurance exists, the reimbursement of the costs can be applied for there. The insurance company decides at its own discretion whether to reimburse the costs or not.
WHAT ACTION IS POSSIBLE AGAINST A REJECTION OF THE APPLICATION FOR COST COVERAGE?
According to the current status, about 2/3 of the applications for cost coverage are approved by the statutory health insurers.
An appeal against a rejection of the application by the responsible health insurance company can be filed within four weeks.
Various formulation aids for an objection can be found online: https://www.widerspruch.org/widerspruch-krankenkasse-du-wissen-solltest/
WHAT IS THE “Substitution Register”?
If the costs for medical cannabis are covered by the statutory health insurance, the patient is obliged to participate in an anonymized accompanying survey.
This survey is carried out for the first time one year after the start of treatment and subsequently annually for the duration of the therapy, or in the event of premature discontinuation of therapy.
For this purpose, the attending physician fills out a questionnaire on the treatment and sends it to the Federal Institute for Drugs and Medical Devices (BfArM).
CAN MEDICAL CANNABIS BE INHALED IN PUBLIC?
In principle, yes. To avoid misunderstandings, it is recommended to carry a copy of the current prescription and a “cannabis ID card”. You can request a corresponding ID card from your doctor or the Arbeitsgemeinschaft Cannabis als Medizin (ACM). Physicians and pharmacists can obtain these ID cards directly from us.
ARE CANNABIS PATIENTS ALLOWED TO DRIVE MOTOR VEHICLES AND HEAVY MACHINERY?
During the adaptation phase, cannabis patients must refrain from driving motor vehicles and heavy machinery. This may last one week or longer. Patients should be sure to follow the dosage and form of administration as discussed with their physician.
WHAT DO CANNABIS PATIENTS HAVE TO BEAR IN MIND WHEN TRAVELING ABROAD?
To carry medical cannabis when traveling within the Schengen area, a “Schengen certificate” issued by the doctor in charge is required. For travels beyond, the conditions for entry with medical cannabis must be obtained from an embassy or consulate of the destination country. Further information can be found on the website of the BfArM: www.bfarm.de.
If you have any further questions, please contact your doctor or pharmacist. If you are missing important information here, you can inform DRAPALIN directly at email@example.com and thus contribute to an improvement of our information offer.